| Literature DB >> 35105628 |
John T Y Soong1,2, Sheryl Hui-Xian Ng3, Kyle Xin Quan Tan3, Jurgita Kaubryte4, Adrian Hopper5.
Abstract
OBJECTIVES: Challenges with manual methodologies to identify frailty, have led to enthusiasm for utilising large-scale administrative data, particularly standardised diagnostic codes. However, concerns have been raised regarding coding reliability and variability. We aimed to quantify variation in coding frailty syndromes within standardised diagnostic code fields of an international dataset.Entities:
Keywords: epidemiology; geriatric medicine; international health services; quality in health care
Mesh:
Year: 2022 PMID: 35105628 PMCID: PMC8808387 DOI: 10.1136/bmjopen-2021-052735
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Volume and percentage of coded frailty syndromes in admission spells
| Country/() | Total spells contributed N (%) | Group 1 dementia and delirium N (%) | Group 2 mobility problems N (%) | Group 3 | Group 4 | Group 5 incontinence N (%) | Group 6 | Group 7 | At least one frailty syndrome coded N (%) |
| Australia | 192 105 (13.7) | 44 804 (23.3) | 8427 (4.4) | 67 263 (35.0) | 19 471 (10.1) | 24 457 (12.7) | 10 220 (5.3) | 9836 (5.1) | 108 491 (56.5) |
| Belgium | 56 016 (4.0) | 9437 (16.8) | 660 (1.2) | 15 348 (27.4) | 5416 (9.7) | 3194 (5.7) | 2460 (4.4) | 3451 (6.2) | 24 989 (44.6) |
| Denmark | 80 869 (5.8) | 3290 (4.1) | 67 (0.1) | 12 940 (16.0) | 642 (0.8) | 176 (0.2) | 157 (0.2) | 775 (1.0) | 16 626 (20.6) |
| Finland | 96 301 (6.9) | 4798 (5.0) | 96 (0.1) | 10 323 (10.7) | 375 (0.4) | 78 (0.1) | 7 (0.0) | 1248 (1.3) | 15 781 (16.4) |
| Italy | 24 052 (1.7) | 681 (2.8) | 131 (0.5) | 1969 (8.2) | 101 (0.4) | 4 (0.0) | 0 (0.0) | 150 (0.6) | 2871 (11.9) |
| Netherlands | 49 574 (3.5) | 3412 (6.9) | 147 (0.3) | 6587 (13.3) | 603 (1.2) | 307 (0.6) | 105 (0.2) | 419 (0.8) | 10 040 (20.3) |
| Norway | 269 214 (19.2) | 26 477 (9.8) | 1722 (0.6) | 50 130 (18.6) | 3065 (1.1) | 555 (0.2) | 453 (0.2) | 5345 (2.0) | 74 228 (27.6) |
| Singapore | 38 484 (2.7) | 5443 (14.1) | 450 (1.2) | 9559 (24.8) | 1694 (4.4) | 195 (0.5) | 1041 (2.7) | 1289 (3.3) | 14 829 (38.5) |
| UK | 384 682 (27.4) | 77 995 (20.3) | 23 635 (6.1) | 113 179 (29.4) | 21 954 (5.7) | 12 648 (3.3) | 14 383 (3.7) | 25 992 (6.8) | 177 775 (46.2) |
| USA | 213 374 (15.2) | 44 735 (21.0) | 4594 (2.2) | 48 789 (22.9) | 14 581 (6.8) | 8858 (4.2) | 509 (0.2) | 40 516 (19.0) | 107 965 (50.6) |
| Total spells | 1 404 671(100) | 221 072 (15.7) | 39 929 (2.8) | 336 087 (23.9) | 67 902 (4.8) | 50 472 (3.6% | 29 335 (2.1) | 89 021 (6.3) | 553 595 (39.4) |
Figure 1Range and mean of percentage coded frailty syndrome groups across the countries from 2010 to 2014, with SD and coefficient of variation (CV) for 2013.
Figure 2Range and mean across frailty syndrome groups for countries by year. CV, coefficient of variation.
Coefficient of variation across all frailty syndrome groups and outcomes for year 2013 within country
| Country | Coefficient of variation across frailty syndrome groups within country | Average mortality rate across frailty syndromes | Average length of hospital stay (days) across frailty syndromes | Average readmission rate across frailty syndromes |
| Australia | 80.5 | 8.9% | 18.4 | 11.5% |
| Belgium | 77.6 | 9.2% | 20.4 | 8.7% |
| Denmark | 166.1 | 7.6% | 8.7 | 15.5% |
| Finland | 147.5 | 3.4% | 8.8 | 11.2% |
| Italy | 164.4 | 7.0% | 16.6 | 6.2% |
| Netherlands | 142.5 | 6.3% | 12.1 | 8.0% |
| Norway | 141.9 | 5.1% | 5.8 | 17.3% |
| UK | 110.7 | 11.9% | 11.2 | 18.7% |
| USA | 82.3 | 5.7% | 17.7 | 14.5% |
| Singapore | 82.6 | 5.1% | 9.8 | 21.9% |
Prevalence of frailty syndromes in observational studies in the secondary care setting
| Frailty syndrome | Lakhan et al, 2011 | Buurman | Edmans | Bell | Soong | This study |
| Anxiety/depression | 21.1% | 29.9% | 2.4% | 6.3% | ||
| Functional dependence | 59.8% | 50.9% | 47% | 1.0% | 2.3% | |
| Falls | 41.9% | 23.3% | 31% | 39.2% | 8.7% | 23.9% |
| Incontinence | 36.7% | 22.2% | 38.6% | 1.1% | 3.6% | |
| Mobility problems | 58.5% | 12% | 2.0% | 2.8% | ||
| Pressure ulcers | 4.9% | 14.9% | 1.1% | 4.8% | ||
| Cognitive impairment | 34.3% | 40.1% | 16% | 25.5% | 9.0% | 15.7% |
| Polypharmacy | 60.7% | |||||
| Malnutrition | 51.5% | 32.8% | 4.8% |